Photodynamic Therapy for Atherosclerosis: Past, Present, and Future
View abstract on PubMed
Summary
This summary is machine-generated.Photodynamic therapy (PDT) offers a targeted, minimally invasive treatment for atherosclerosis, a major cardiovascular disease. Research explores PDT
Area Of Science
- Cardiovascular Research
- Medical Technology
- Oncology (Therapeutic Applications)
Background
- Atherosclerosis, a leading cause of cardiovascular disease, involves arterial lipid accumulation and inflammation.
- Current treatments focus on risk factors, but inflammation's role is increasingly recognized.
- Minimally invasive strategies are needed to address the high morbidity and mortality associated with atherosclerosis.
Purpose Of The Study
- To review the evolution and potential of photodynamic therapy (PDT) for treating atherosclerosis.
- To explore PDT's mechanistic basis, preclinical efficacy, and application in plaque stabilization.
- To identify future research needs for clinical translation of PDT in cardiovascular medicine.
Main Methods
- Review of existing literature on photodynamic therapy (PDT) and atherosclerosis.
- Analysis of PDT's mechanism involving photosensitizers, light, and oxygen.
- Examination of preclinical data on PDT's effects on atherosclerotic plaques and macrophage infiltration.
Main Results
- PDT demonstrates targeted cell death in diseased arterial tissue, sparing healthy cells.
- Nanoparticle advancements enhance PDT delivery and therapeutic potential.
- Preclinical studies suggest PDT can improve plaque stability and reduce macrophage density.
Conclusions
- Photodynamic therapy (PDT) presents a promising, targeted approach for atherosclerosis treatment.
- Further research is required to optimize PDT parameters, manage side effects, and confirm long-term clinical outcomes.
- PDT has the potential to significantly advance atherosclerosis management from research to clinical practice.

